Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma

Journal of Pain Research

Volumn 4, Issue , 2011, Pages 25-38

  Nicolaou, Andrew ^a   Nicholson, Bruce ^b   Hans, Guy ^c   Brasseur, Louis ^d  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b Antwerp University Hospital ^*

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d INSTITUT CURIE   (France)

Author keywords

Case report; Lidocaine plaster; Low back pain; Neuropathic pain; Surgical and nonsurgical trauma pain

Indexed keywords

AMITRIPTYLINE; CAPSAICIN; CHLORDIAZEPOXIDE PLUS CLIDINIUM BROMIDE; LANSOPRAZOLE; LIDOCAINE; NAPROXEN; NARCOTIC ANALGESIC AGENT; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PREGABALIN; TRAMADOL; TRIMETAZIDINE; UNCLASSIFIED DRUG; VERSATIS;

ADD ON THERAPY; ALLODYNIA; ANXIETY; APPLICATION SITE REACTION; ARTICLE; CHRONIC PAIN; COMBINATION CHEMOTHERAPY; DEPRESSION; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; DYSESTHESIA; HUMAN; HYPERALGESIA; LOW BACK PAIN; MONOTHERAPY; NEUROPATHIC PAIN; PAIN; PARESTHESIA; PREDICTION; PREDICTIVE VALUE; SIDE EFFECT; SOMNOLENCE; SUICIDAL IDEATION; SURGICAL INJURY; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VERTIGO; VOMITING;

EID: 79953140494     PISSN: 11787090     EISSN: None     Source Type: Journal    
DOI: 10.2147/JPR.S15534     Document Type: Article

References (31)

1. Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: An overview and literature update. Mayo Clin Proc. 2010;85 Suppl 3:S3-S14.
2. Argoff CE. New analgesics for neuropathic pain: The lidocaine patch. Clin J Pain. 2000;16:S62-S66.
3. Baron R, Mayoral V, Leijon G, et al. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: An open-label, non-inferiority two-stage RCT study. Curr Med Res Opin. 2009;25:1663-1676.
4. Baron R, Mayoral V, Leijon G, et al. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in postherpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin. 2009;25:1677-1687.
5. Binder A, Bruxelle J, Rogers P, et al. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: Results of a double-blind, placebo-controlled, multinational efficacy and safety trial. Clin Drug Investig. 2009;29:393-408.
6. Hans G, Sabatowski R, Binder A, et al. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: Results of a long-term study. Curr Med Res Opin. 2009;25: 1295-1305.
7. Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: Double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain. 1996;65:39-44.
8. Barbano RL, Herrmann DN, Hart-Gouleau S, et al. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol. 2004;61:914-918.
9. Herrmann DN, Barbano RL, Hart-Gouleau S, et al. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Pain Med. 2005;6:379-384.
10. Nalamachu S, Crockett RS, Gammaitoni AR, Gould EM. A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: A 6-week, randomized, parallel-group study. MedGenMed. 2006;8:33.
11. Hans G, Joukes E, Verhulst J, Vercauteren M. Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: Study of 40 consecutive cases. Curr Med Res Opin. 2009;25: 2737-2743.
12. Brabant S, Nagels W. Topical lidocaine 5% patch for the treatment of chronic postsurgical neuropathic skin pain. Pain Pract. 2009;9(S1):35.
13. Galer BS, Gammaitoni AR, Oleka N, et al. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain. Curr Med Res Opin. 2004;20 Suppl 2:S5-S12.
14. Gimbel J, Linn R, Hale M, Nicholson B. Lidocaine patch treatment in patients with low back pain: Results of an open-label, nonrandomized pilot study. Am J Ther. 2005;12:311-319.
15. Hines R, Keaney D, Moskowitz MH, Prakken S. Use of lidocaine patch 5% for chronic low back pain: A report of four cases. Pain Med. 2002; 3:361-365.
16. Braun J, Inman R. Clinical significance of inflammatory back pain for diagnosis and screening of patients with axial spondyloarthritis. Ann Rheum Dis. 2010;69:1264-1268.
17. Argoff CA, Wheeler AH. Spinal and radicular pain disorders. Neurol Clin. 1998;16:833-850.
18. Wheeler AH, Murrey DB. Spinal pain: Pathogenesis, evolutionary mechanisms, and management. In: Pappagallo M, editor. The Neurological Basis of Pain. McGraw-Hill; 2005.
19. Kirkaldy-Willis WH, Wedge JH, Yong-Hing K, Reilly J. Pathology and pathogenesis of lumbar spondylosis and stenosis. Spine (Phila Pa 1976).1978;3:319-328.
20. Selby DK. The structural degenerative cascade: The lumbar spine. In: White AH, Schofferman JA, editors. Spine Care: Diagnosis and Conservative Treatment. St Louis, MO: Mosby; 1995.
21. Freynhagen R, Baron R. The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep. 2009;13:185-190.
22. Bogduk N. On the definitions and physiology of back pain, referred pain, and radicular pain. Pain. 2009;147:17-19.
23. Macrae WA. Chronic post-surgical pain: 10 years on. Br J Anaesth. 2008;101:77-86.
24. Mahn F, Baron R. Types of topical treatment for peripheral neuropathic pain. Mechanism of action and indications. Schmerz. 2010;24:317-325. German.
25. O'Connor AB, Dworkin RH. Treatment of neuropathic pain: An overview of recent guidelines. Am J Med. 2009;122(10 Suppl):S22-S32.
26. Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: A randomized, double-blind, placebo-controlled study. Pain. 2003;106:151-158.
27. Wasner G, Kleinert A, Binder A, et al. Postherpetic neuralgia: Topical lidocaine is effective in nociceptor-deprived skin. J Neurol. 2005;252:677-686.
28. Jensen TS, Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain. 2003;102:1-8.
29. Maier C, Baron R, Tölle TR, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain. 2010;150:439-450.
30. Rolke R, Baron R, Maier C, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values. Pain. 2006;123:231-243.
31. Baron R, Binder A, Wasner G. Neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807-819.